Bone Biologics Corp (BBLGW) EBITDA (2010 - 2025)
Bone Biologics (BBLGW) posted quarterly EBITDA of -$733105.0 for Q4 2025, up 52.85% year-over-year from -$479614.1 in Q4 2024, and down 2.49% quarter-over-quarter from -$715274.0 in Q3 2025.
Bone Biologics Corp (BBLGW) EBITDA (2010 - 2025) Analysis & Trends
Bone Biologics (BBLGW) has reported EBITDA for 16 consecutive years, with -$733105.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, EBITDA rose 52.85% year-over-year to -$733105.0; the TTM figure through Dec 2025 stood at -$3.2 million (up 23.33% YoY), while the FY2025 annual figure was -$3.2 million, up 23.33% from the prior year.
- EBITDA declined to -$733105.0 in Q4 2025 per BBLGW's latest filing, from -$715274.0 in the prior quarter.
- Across five years, EBITDA topped out at -$180924.0 in Q1 2021 and bottomed at -$3.1 million in Q1 2023.
- Historically, EBITDA has averaged -$1.1 million across 5 years, with a median of -$856600.5 in 2024.
- Annual changes were most pronounced in 2023 — EBITDA plunged 547.74% — and 2024, when it soared 73.37%.
- Bone Biologics' EBITDA stood at -$460482.0 in 2021, then tumbled by 179.51% to -$1.3 million in 2022, then increased by 9.87% to -$1.2 million in 2023, then tumbled by 34.05% to -$1.6 million in 2024, then surged by 52.85% to -$733105.0 in 2025.
- Business Quant data shows BBLGW's EBITDA at -$733105.0 in Q4 2025, -$715274.0 in Q3 2025, and -$748075.0 in Q2 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -733,105.00 |
| Sep 30, 2025 | -715,274.00 |
| Jun 30, 2025 | -748,075.00 |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | -951,021.00 |
| Jun 30, 2024 | -809,665.00 |
| Mar 31, 2024 | -903,536.00 |
| Dec 31, 2023 | -1.16 Mn |
| Sep 30, 2023 | -2.08 Mn |
| Jun 30, 2023 | -3.04 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -469,304.00 |
| Mar 31, 2022 | -689,499.00 |
| Dec 31, 2021 | -460,482.00 |
| Sep 30, 2021 | -229,789.00 |
| Jun 30, 2021 | -231,881.00 |
| Mar 31, 2021 | -180,924.00 |